Abstract
The effects of antiobesity medication can include cardiac valvular disorders and pulmonary hypertension. Fenfluramine, phentermine, and dexfenfluramine are particularly prone to cause these problems. Sudden hypotension with administration of general anesthesia in patients who have taken antiobesity drugs has been reported. The cosmetic surgeon should question patients regarding intake of antiobesity medications and should consider cardiac workup prior to performing surgery.
Get full access to this article
View all access options for this article.
References
1.
Jeffers
LA
: Anesthetic considerations for the new antiobesity medications . J Am Assoc Nurse Anesth 1996 ;64 :541 –544 .
2.
Langleben
D
: Familial primary pulmonary hypertension . Chest 1994 ;105 (Suppl. ):13S –16S .
3.
Hadengrie
A
Benhayorim
MK
Lebrec
D
Benhamore
JP
: Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics . Gastroenterology 1991 ;100 :520 –528 .
4.
McDonnell
PJ
Toye
PA
Hutchins
GM
: Primary pulmonary hypertension and cirrhosis: Are they related? Am Rev Respir Dis 1983 ;127 :437 –441 .
5.
Dawkins
KD
Burke
CM
Billingham
ME
Jamieson
SW
: Primary pulmonary hypertension and pregnancy . Chest 1986 ;89 :383 –388 .
6.
Collins
E
Hardwick
H
Jeffery
H
: Perinatal cocaine intoxication . Med J Aust 1989 ;150 :331 –332 .
7.
Legoux
B
Piette
AM
Bouchet
PE
Laudau
JF
Gepner
P
Chapman
AM
: Pulmonary hypertension and HIV infection . Am J Med 1990 ;89 :122 .
8.
Kleiger
RE
Boxers
M
Ingham
RE
Harrison
DC
: Pulmonary hypertension in patients using oral contraceptives: A report of six cases . Chest 1976 ;69 : 143 –147 .
9.
Masi
AT
: Pulmonary hypertension and oral contraceptive usage . Chest 1976 ;69 :451 –453 .
10.
Abenhaim
L
Moride
Y
Brenot
F
: Appetite-suppressant drugs and the risk of primary pulmonary hypertension . N Engl J Med 1996 ;335 :609 –616 .
11.
Brenot
F
Herve
P
Petitpretz
P
Parent
F
Duroux
P
Simonneau
G
: Primary pulmonary hypertension and fenfluramine use . Br Heart J 1993 ;70 :537 –541 .
12.
Douglas
JG
Munro
JF
Kitchin
AH
Muir
AL
Proudfoot
AT
: Pulmonary hypertension and fenfluramine . BMJ 1981 ;283 :881 –883 .
13.
Gurtner
HP
: Aminorex and pulmonary hypertension . Cor Vasa 1985 ;27 :160 –171 .
14.
Mark
EJ
Patalas
ED
Chang
HT
: Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine . N Engl J Med 1997 ;337 :602 –606 .
15.
McMurray
J
Bloomfield
P
Miller
HC
: Irreversible pulmonary hypertension after treatment with fenfluramine . Br Med J 1986 ;29 :51 –52 .
16.
Connolly
HM
Garry
JL
McGoon
MD
: Valvular heart disease associated with fenfluramine-phentermine . N Engl J Med 1997 ;337 :581 –588 .
17.
Graham
DJ
Green
L
: Further cases of valvular heart disease associated with fenfluramine-phentermine . N Engl J Med 1997 ;337 :635 .
18.Food and Drug Administration : Medical Products Reporting Program (Med Watch) , March 1997 .